Status:
COMPLETED
Identification of Patients With High Probability of Poorly Responding to Therapy With Mycophenolic Acid Prodrugs
Lead Sponsor:
Medical University of Vienna
Collaborating Sponsors:
Novartis
Conditions:
Renal Transplantation
Eligibility:
All Genders
18-75 years
Brief Summary
This study is designed to define groups of patients (among patients with a heart or kidney graft or a glomerular disease and nephrotic range proteinuria) who would either not profit from a therapy wit...
Eligibility Criteria
Inclusion
- patients with a de novo kidney graft and age \>18 and \< 75
Exclusion
- pregnancy
- panel of antigens reactivity \> 40%
Key Trial Info
Start Date :
October 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 9 2020
Estimated Enrollment :
277 Patients enrolled
Trial Details
Trial ID
NCT00978965
Start Date
October 1 2009
End Date
September 9 2020
Last Update
September 10 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Medicine III, Division of Nephrology
Vienna, Austria, A-1090